Opportunity Information: Apply for RFA EY 14 001
Apply for RFA EY 14 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NEI Audacious Goal Initiative Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.867 Vision Research.
- This funding opportunity was created on Apr 23, 2014 and posted on Apr 23, 2014.
- Applicants must submit their applications by Aug 14, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $700,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Public housing authorities/Indian housing authorities Special district governments County governments Independent school districts State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "NEI Audacious Goal Initiative Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)" is a National Institutes of Health (NIH) National Eye Institute (NEI) cooperative agreement program designed to push forward a specific long-term vision: restoring vision by regenerating neurons and the neural connections involved in the eye and the broader visual system. It sits within the NEI Audacious Goal Initiative (AGI), a strategic planning effort that singled out one central "audacious goal" focused on repairing or replacing the neural components that are lost or damaged in major blinding conditions. In practical terms, the initiative is aimed at two major biological and clinical problems: the loss of photoreceptor cells, which can occur due to inherited retinal degeneration, age-related processes, trauma, or other diseases, and the degeneration or injury of retinal ganglion cells, which is a hallmark of glaucoma and optic neuropathies. The announcement frames this as not only a disease problem but a technical challenge, emphasizing the need for imaging approaches that can measure, track, and ultimately guide progress toward regeneration and reconnection of these neurons.
A key point in the opportunity is that it is not just about incremental improvements to existing tools. The emphasis is on addressing technical needs and opening up new opportunities specifically for imaging the visual system in ways that meaningfully support the audacious goal. Imaging is essential here because regeneration and reconnection are processes that need to be observed, quantified, and validated over time. For example, researchers need methods that can visualize cell survival, structural restoration, connectivity changes, and functional recovery in the retina, optic nerve, and central visual pathways. Even though the short summary does not list specific technology areas, the intent is clear: enable and accelerate work on nerve regeneration by improving the ability to see what is happening in living systems, ideally with measurements that are sensitive, reliable, and relevant to disease and treatment development. This can include imaging approaches that help establish whether a treatment is working, how it is working, and which patients or models respond best.
The opportunity also aligns with two broader programmatic priorities identified through the AGI planning process. The first is developing new treatments for eye disease using molecular approaches, which points toward biologically targeted interventions such as gene-based therapies, biologics, small molecules, or other molecular strategies intended to protect, restore, or regenerate retinal neurons and their connections. The second is understanding how aging intersects with the biological mechanisms of eye disease. This matters because many blinding disorders are age-associated and because the capacity for neural repair often changes with age. Imaging tools that can capture age-related changes, distinguish normal aging from disease processes, or assess how aging affects therapeutic response would directly support that priority.
From an administrative and funding standpoint, this is a discretionary grant made under a cooperative agreement mechanism (U01). A cooperative agreement generally means there is expected to be substantial scientific or programmatic involvement from NIH staff compared to a standard investigator-initiated grant. In other words, the government is not just providing funds and stepping away; it typically collaborates more actively to keep the work aligned with program goals, milestones, and coordination needs. The activity category is health, and the CFDA listing is 93.867 (Vision Research). The award ceiling listed is $700,000, and the announcement specifies that there is no cost sharing or matching requirement, so applicants are not required to contribute non-federal funds as a condition of award.
The eligibility for this opportunity is broad and includes a wide range of organization types. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), state, county, city/township, and special district governments, independent school districts, tribal governments and tribal organizations, public housing authorities/Indian housing authorities, and both small businesses and for-profit organizations (including those other than small businesses). The eligibility section also explicitly includes a number of institution categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIs, as well as faith-based or community-based organizations. Importantly, non-U.S. entities are eligible to apply, foreign institutions and foreign organizations are allowed, and foreign components of U.S. organizations are permitted consistent with NIH policy. This broad eligibility suggests NEI was looking to attract expertise wherever it exists, including industry and international teams, which is consistent with a technology- and tool-development driven imaging effort.
Key dates in the listing show that the opportunity was posted and created on April 23, 2014, with an original and current closing date of August 14, 2014, and an archive date of September 14, 2014. These dates indicate the announcement is no longer active, but the summary remains useful for understanding the kind of imaging-focused capabilities NEI sought to support under the Audacious Goal Initiative at that time. The administering agency is NIH, and the announcement provides a link to the full solicitation in the NIH Grants Guide (RFA-EY-14-001), which would contain the detailed scope, application requirements, review criteria, expected deliverables, and any special cooperative agreement terms. For technical issues accessing the announcement, the contact point listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: NEI Audacious Goal Initiative - Imaging the Visual System (U01)
What is the title of this funding opportunity?
The opportunity is titled "NEI Audacious Goal Initiative Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)."
Which agency is offering this grant?
The administering agency is the National Institutes of Health (NIH), through the National Eye Institute (NEI).
What is the broader program this opportunity belongs to?
This opportunity sits within the NEI Audacious Goal Initiative (AGI), a strategic planning effort focused on a central long-term goal related to vision restoration.
What is the audacious goal behind this program?
The stated long-term vision is restoring vision by regenerating neurons and the neural connections involved in the eye and the broader visual system.
What kinds of scientific or clinical problems is the initiative trying to address?
The summary highlights two major problem areas: (1) loss of photoreceptor cells (which can occur due to inherited retinal degeneration, age-related processes, trauma, or other diseases) and (2) degeneration or injury of retinal ganglion cells (a hallmark of glaucoma and optic neuropathies).
What is the main technical focus of this specific opportunity?
The emphasis is on imaging the visual system and addressing technical needs and opportunities for imaging approaches that can meaningfully support regeneration and reconnection of neurons.
Is this opportunity focused on incremental improvements to existing tools?
No. The summary explicitly emphasizes that it is not just about incremental improvements, but about addressing technical needs and opening new opportunities for imaging the visual system in ways that support the audacious goal.
Why is imaging considered essential for this initiative?
Because regeneration and reconnection are processes that need to be observed, quantified, and validated over time. Imaging tools can help visualize and measure changes such as cell survival, structural restoration, connectivity changes, and functional recovery.
What parts of the visual system are referenced as targets for imaging?
The summary references the retina, optic nerve, and central visual pathways.
What kinds of measurements or outcomes might imaging tools need to capture?
Based on the summary, imaging approaches may need to support visualization and tracking of cell survival, structural restoration, changes in connectivity, and indicators of functional recovery over time in living systems.
How does this opportunity relate to treatment development?
The summary suggests imaging tools can help establish whether a treatment is working, how it is working, and which patients or models respond best, thereby enabling and accelerating development efforts aligned with regeneration and reconnection goals.
What broader programmatic priorities does this opportunity align with?
It aligns with two priorities identified through the AGI planning process: (1) developing new treatments for eye disease using molecular approaches and (2) understanding how aging intersects with the biological mechanisms of eye disease.
What does "molecular approaches" mean in the context provided?
The summary points to biologically targeted interventions such as gene-based therapies, biologics, small molecules, or other molecular strategies intended to protect, restore, or regenerate retinal neurons and their connections.
Why is aging highlighted as a priority area?
Because many blinding disorders are age-associated and the capacity for neural repair often changes with age. Imaging that can capture age-related changes, distinguish normal aging from disease processes, or assess how aging affects therapeutic response would support this priority.
What type of funding mechanism is used?
This is a cooperative agreement under the U01 mechanism.
What does a cooperative agreement (U01) imply about NIH involvement?
The summary explains that a cooperative agreement generally involves substantial scientific or programmatic involvement from NIH staff compared with a standard investigator-initiated grant, meaning NIH may collaborate more actively to keep work aligned with program goals, milestones, and coordination needs.
What is the activity category and CFDA number listed?
The activity category is health, and the CFDA listing is 93.867 (Vision Research).
What is the maximum award amount (ceiling) listed for this opportunity?
The award ceiling listed is $700,000.
Is cost sharing or matching required?
No. The announcement specifies there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including public and state-controlled institutions of higher education; private institutions of higher education; nonprofits (501(c)(3) and non-501(c)(3)); state, county, city/township, and special district governments; independent school districts; tribal governments and tribal organizations; public housing authorities/Indian housing authorities; and both small businesses and for-profit organizations (including those other than small businesses).
Are minority-serving institutions explicitly included?
Yes. The eligibility section explicitly includes categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIs.
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are explicitly included in the eligibility description.
Are foreign (non-U.S.) entities allowed to apply?
Yes. Non-U.S. entities are eligible, including foreign institutions and foreign organizations, and foreign components of U.S. organizations are permitted consistent with NIH policy.
When was the opportunity posted and when did it close?
The listing shows it was posted/created on April 23, 2014. The original and current closing date is August 14, 2014. The archive date is September 14, 2014.
Is this funding opportunity still active?
No. The closing and archive dates indicate the announcement is no longer active.
Where can applicants find the full solicitation details?
The summary references a link to the full solicitation in the NIH Grants Guide: RFA-EY-14-001. The full solicitation would contain detailed scope, application requirements, review criteria, expected deliverables, and any special cooperative agreement terms.
Who is the listed contact for technical issues accessing the announcement?
The contact point listed for technical issues accessing the announcement is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: FY 2015 Teacher Exchange Program
Previous opportunity: BLM CA Challenge Cost Share Program Cooperative Ecosystem Studies Units California State University Chico Cultural Recources Recordation
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA EY 14 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA EY 14 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Native Hawaiian Health Care Improvement Act Apply for HRSA 14 096 Funding Number: HRSA 14 096 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving the Capacity of Panel Physicians Performing Overseas Medical Examinations of U.S. Bound Immigrants and Refugees Apply for CDC RFA CK14 1403 Funding Number: CDC RFA CK14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Genomic Resource Grants for Community Resource Projects (U41) Apply for PAR 14 191 Funding Number: PAR 14 191 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alliance for Innovation on Maternal HealthImproving Maternal Health and Safety Apply for HRSA 14 134 Funding Number: HRSA 14 134 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers (P30) Apply for PAR 14 178 Funding Number: PAR 14 178 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) Apply for PAR 14 192 Funding Number: PAR 14 192 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Epidemiology and Prevention in Alcohol Research (R21) Apply for PA 14 188 Funding Number: PA 14 188 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epidemiology and Prevention in Alcohol Research (R03) Apply for PA 14 189 Funding Number: PA 14 189 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Epidemiology and Prevention in Alcohol Research (R01) Apply for PA 14 190 Funding Number: PA 14 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for Tribal Behavioral Health Apply for SM 14 013 Funding Number: SM 14 013 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $200,000 |
| Emerging Pandemic Threats Program 2, PREDICT 2 Apply for RFA OAA 14 000019 Funding Number: RFA OAA 14 000019 Agency: Agency for International Development Category: Health Funding Amount: $100,000,000 |
| Sickle Cell Disease Treatment Demonstration Program Regional Collaborative Apply for HRSA 14 078 Funding Number: HRSA 14 078 Agency: Health Resources and Services Administration Category: Health Funding Amount: $850,000 |
| Immunization Information Systems (IIS) Capacity Building Apply for CDC RFA IP12 120103CONT14 Funding Number: CDC RFA IP12 120103CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partner and Implement Public Health Strategies Related to Apply for CDC RFA DP10 100305CONT14 Funding Number: CDC RFA DP10 100305CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Planning Grant for Global Infectious Disease Research Training Program (D71) Apply for PAR 14 194 Funding Number: PAR 14 194 Agency: National Institutes of Health Category: Health Funding Amount: $28,000 |
| Global Infectious Disease Research Training Program (D43) Apply for PAR 14 193 Funding Number: PAR 14 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Initiative for Minority Men (AIMM) Apply for MP CPI 14 002 Funding Number: MP CPI 14 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $375,000 |
| Centers of Excellence in Genomic Science (CEGS) (RM1) Apply for PAR 14 195 Funding Number: PAR 14 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 14 003 Funding Number: RFA NS 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Economic Studies of Vaccines and Immunization Policies, Programs, and Practices for Adults Apply for CDC RFA IP14 1403 Funding Number: CDC RFA IP14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA EY 14 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
